Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Fly Intel: Top five analyst upgrades » 09:56
10/26/21
10/26
09:56
10/26/21
09:56
FB

Facebook

$327.00 /

-1.66 (-0.51%)

, NVST

Envista

$38.42 /

+0.005 (+0.01%)

, SLP

Simulations Plus

$45.06 /

+3.59 (+8.66%)

, BALY

Bally's

$52.18 /

+2.58 (+5.20%)

, COTY

Coty

$8.34 /

+0.33 (+4.12%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at Rosenblatt with analyst Mark Zgutowicz saying that he thinks the stock looks "oversold" following last night's "reset" and that he sees limited near-term downside with over 20% upside given the "more stable" near-term expectations. 2. Envista (NVST) upgraded to Buy from Neutral at BofA with analyst Michael Cherny saying the investment story continues to evolve with further margin progression and portfolio optimization setting up the company for potential accretive M&A. 3. Simulations Plus (SLP) upgraded to Buy from Hold at Craig-Hallum with analyst Matt Hewitt saying the company's Q4 report demonstrates that the company's services business has begun to recover. 4. Bally's (BALY) upgraded to Outperform from Market Perform at Cowen with analyst Lance Vitanza saying Bally's completed its acquisition of Gamesys on October 1 and expects to officially launch its Bally Bet app in early 2022. 5. Coty (COTY) upgraded to Buy from Hold at Deutsche Bank with analyst Steve Powers saying the stock is down 20% off its recent highs despite the "legitimately strong and promising" fiscal Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SLP Simulations Plus
$45.06 /

+3.59 (+8.66%)

NVST Envista
$38.42 /

+0.005 (+0.01%)

FB Facebook
$327.00 /

-1.66 (-0.51%)

COTY Coty
$8.34 /

+0.33 (+4.12%)

BALY Bally's
$52.18 /

+2.58 (+5.20%)

FB Facebook
$327.00 /

-1.66 (-0.51%)

10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Monness Crespi
Facebook price target lowered to $460 from $500 at Monness Crespi
10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
NVST Envista
$38.42 /

+0.005 (+0.01%)

10/26/21 BofA
Envista upgraded to Buy from Neutral at BofA
10/26/21 BofA
Envista upgraded to Buy from Neutral at BofA
09/30/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
SLP Simulations Plus
$45.06 /

+3.59 (+8.66%)

10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
07/13/21 Raymond James
Simulations Plus price target lowered to $54 from $95 at Raymond James
04/13/21 Craig-Hallum
Simulations Plus price target lowered to $74 from $81 at Craig-Hallum
BALY Bally's
$52.18 /

+2.58 (+5.20%)

10/26/21 Cowen
Bally's upgraded to Outperform at Cowen on online betting bullishness
10/26/21 Cowen
Bally's upgraded to Outperform from Market Perform at Cowen
09/14/21 Wells Fargo
Bally's initiated with an Equal Weight at Wells Fargo
06/28/21 Stifel
Bally's price target raised to $81 from $75 at Stifel
COTY Coty
$8.34 /

+0.33 (+4.12%)

10/26/21 Deutsche Bank
Deutsche Bank upgrades Coty to Buy after 20% pullback
10/26/21 Deutsche Bank
Coty upgraded to Buy from Hold at Deutsche Bank
09/09/21 Deutsche Bank
Coty secondary offering sends 'negative signal,' says Deutsche Bank
08/27/21 Deutsche Bank
Coty price target raised to $10 from $9 at Deutsche Bank
SLP Simulations Plus
$45.06 /

+3.59 (+8.66%)

NVST Envista
$38.42 /

+0.005 (+0.01%)

FB Facebook
$327.00 /

-1.66 (-0.51%)

COTY Coty
$8.34 /

+0.33 (+4.12%)

BALY Bally's
$52.18 /

+2.58 (+5.20%)

  • 08
    Sep
  • 16
    Apr
NVST Envista
$38.42 /

+0.005 (+0.01%)

FB Facebook
$327.00 /

-1.66 (-0.51%)

COTY Coty
$8.34 /

+0.33 (+4.12%)

BALY Bally's
$52.18 /

+2.58 (+5.20%)

SLP Simulations Plus
$45.06 /

+3.59 (+8.66%)

FB Facebook
$327.00 /

-1.66 (-0.51%)

COTY Coty
$8.34 /

+0.33 (+4.12%)

BALY Bally's
$52.18 /

+2.58 (+5.20%)

SLP Simulations Plus
$45.06 /

+3.59 (+8.66%)

FB Facebook
$327.00 /

-1.66 (-0.51%)

COTY Coty
$8.34 /

+0.33 (+4.12%)

Upgrade
Envista upgraded to Buy from Neutral at BofA » 06:11
10/26/21
10/26
06:11
10/26/21
06:11
NVST

Envista

$38.42 /

-0.665 (-1.70%)

BofA analyst Michael…

BofA analyst Michael Cherny upgraded Envista to Buy from Neutral with a price target of $48, down from $49. The investment story continues to evolve with further margin progression and portfolio optimization setting up the company for potential accretive M&A, the analyst tells investors in a research note. Despite these positives, the stock has been under pressure since Q2 earnings due to "macro questions about utilization recovery", Cherny adds.

ShowHide Related Items >><<
NVST Envista
$38.42 /

-0.665 (-1.70%)

NVST Envista
$38.42 /

-0.665 (-1.70%)

10/26/21 BofA
Envista upgraded to Buy from Neutral at BofA
09/30/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
NVST Envista
$38.42 /

-0.665 (-1.70%)

NVST Envista
$38.42 /

-0.665 (-1.70%)

Upgrade
Envista upgraded to Buy from Neutral at BofA » 06:02
10/26/21
10/26
06:02
10/26/21
06:02
NVST

Envista

$38.42 /

-0.665 (-1.70%)

BofA analyst Michael…

BofA analyst Michael Cherny upgraded Envista to Buy from Neutral with a price target of $48, down from $49.

ShowHide Related Items >><<
NVST Envista
$38.42 /

-0.665 (-1.70%)

NVST Envista
$38.42 /

-0.665 (-1.70%)

09/30/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
NVST Envista
$38.42 /

-0.665 (-1.70%)

NVST Envista
$38.42 /

-0.665 (-1.70%)

Over a week ago
Initiation
Envista assumed with an Outperform at Credit Suisse » 16:56
09/30/21
09/30
16:56
09/30/21
16:56
NVST

Envista

$41.86 /

-1.035 (-2.41%)

Credit Suisse analyst…

Credit Suisse analyst Matt Miksic assumed coverage of Envista with an Outperform rating and $55 price target.

ShowHide Related Items >><<
NVST Envista
$41.86 /

-1.035 (-2.41%)

NVST Envista
$41.86 /

-1.035 (-2.41%)

09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
NVST Envista
$41.86 /

-1.035 (-2.41%)

NVST Envista
$41.86 /

-1.035 (-2.41%)

NVST Envista
$41.86 /

-1.035 (-2.41%)

Conference/Events
Envista management to meet virtually with Piper Sandler » 04:55
09/27/21
09/27
04:55
09/27/21
04:55
NVST

Envista

$43.25 /

+0.58 (+1.36%)

Virtual Meeting to be…

Virtual Meeting to be held on September 27 hosted by Piper Sandler.

ShowHide Related Items >><<
NVST Envista
$43.25 /

+0.58 (+1.36%)

NVST Envista
$43.25 /

+0.58 (+1.36%)

09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
NVST Envista
$43.25 /

+0.58 (+1.36%)

NVST Envista
$43.25 /

+0.58 (+1.36%)

NVST Envista
$43.25 /

+0.58 (+1.36%)

Over a month ago
Conference/Events
Envista management to meet virtually with Piper Sandler » 14:19
09/20/21
09/20
14:19
09/20/21
14:19
NVST

Envista

$41.57 /

-0.94 (-2.21%)

Virtual Meeting to be…

Virtual Meeting to be held on September 27 hosted by Piper Sandler.

ShowHide Related Items >><<
NVST Envista
$41.57 /

-0.94 (-2.21%)

NVST Envista
$41.57 /

-0.94 (-2.21%)

09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
NVST Envista
$41.57 /

-0.94 (-2.21%)

NVST Envista
$41.57 /

-0.94 (-2.21%)

NVST Envista
$41.57 /

-0.94 (-2.21%)

Hot Stocks
Envista announces intended sale of KaVo Treatment Unit, Instrument to Planmeca » 08:54
09/07/21
09/07
08:54
09/07/21
08:54
NVST

Envista

$43.38 /

-0.61 (-1.39%)

Envista Holdings…

Envista Holdings announced it entered into a binding agreement to sell its KaVo Treatment Unit and Instrument business to planmeca Verwaltungs GmbH for up to $455M, which includes a potential earn-out payment of up to $30M. The sale is expected to close at the end of 2021. The revenue of the business to be sold was approximately $357M and $317M in fiscal years 2019 and 2020, respectively. KaVo Treatment Unit & Instruments is a global developer, manufacturer, and supplier of industry defining dental treatment units and instruments. The business to be sold is part of Envista's Equipment & Consumables segment. Envista's Imaging business, which also currently uses the KaVo brand for select products, will stay with Envista as part of the Equipment & Consumables segment. It is expected that the KaVo Treatment Unit and Instrument business will be reported as a discontinued operation beginning with Envista's third quarter 2021 10-Q filing. The transaction is subject to the satisfaction of certain customary closing conditions, including the receipt of applicable regulatory approvals. The transaction is not subject to financing conditions or a shareholder vote.

ShowHide Related Items >><<
NVST Envista
$43.38 /

-0.61 (-1.39%)

NVST Envista
$43.38 /

-0.61 (-1.39%)

09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
NVST Envista
$43.38 /

-0.61 (-1.39%)

NVST Envista
$43.38 /

-0.61 (-1.39%)

NVST Envista
$43.38 /

-0.61 (-1.39%)

Recommendations
Stifel ups Patterson Companies target to $32 following quarterly results » 14:45
09/02/21
09/02
14:45
09/02/21
14:45
PDCO

Patterson Companies

$32.27 /

+2.07 (+6.85%)

, ALGN

Align Technology

$729.00 /

+10.555 (+1.47%)

, NVST

Envista

$43.74 /

+0.95 (+2.22%)

Stifel analyst Jonathan…

Stifel analyst Jonathan Block raised the firm's price target on Patterson Companies (PDCO) to $32 from $30 and keeps a Hold rating on the shares. The analyst notes Patterson reported "relatively solid" Q1 results with top and bottom-line upside and a modest raise to full year 2022 guidance. While Block acknowledges that the quarter was "solid," he points out that his estimates remain largely unchanged and he continues to prefer other areas within the dental industry as Align Technology (ALGN) and Envista (NVST) remain his #1 and #2 picks in the industry, respectively.

ShowHide Related Items >><<
PDCO Patterson Companies
$32.27 /

+2.07 (+6.85%)

NVST Envista
$43.74 /

+0.95 (+2.22%)

ALGN Align Technology
$729.00 /

+10.555 (+1.47%)

PDCO Patterson Companies
$32.27 /

+2.07 (+6.85%)

09/02/21 Piper Sandler
Patterson Companies remains 'a top value idea,' says Piper Sandler
09/02/21 Piper Sandler
Patterson Q1 results should support 'modest move higher,' says Piper Sandler
08/31/21 Piper Sandler
Piper Sandler a buyer of Patterson Companies into Q1 results
08/05/21
Fly Intel: Top five analyst initiations
ALGN Align Technology
$729.00 /

+10.555 (+1.47%)

08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Align Technology assumed with an Outperform at Credit Suisse
07/29/21 Credit Suisse
Align Technology price target raised to $732 from $715 at Credit Suisse
07/29/21 Piper Sandler
Align Technology price target raised to $775 from $735 at Piper Sandler
NVST Envista
$43.74 /

+0.95 (+2.22%)

08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
PDCO Patterson Companies
$32.27 /

+2.07 (+6.85%)

NVST Envista
$43.74 /

+0.95 (+2.22%)

ALGN Align Technology
$729.00 /

+10.555 (+1.47%)

PDCO Patterson Companies
$32.27 /

+2.07 (+6.85%)

PDCO Patterson Companies
$32.27 /

+2.07 (+6.85%)

NVST Envista
$43.74 /

+0.95 (+2.22%)

ALGN Align Technology
$729.00 /

+10.555 (+1.47%)

ALGN Align Technology
$729.00 /

+10.555 (+1.47%)

Periodicals
Medicare might cover dental care as part of large budget bill, NY Times reports » 09:49
08/30/21
08/30
09:49
08/30/21
09:49
SDC

SmileDirectClub

$5.33 /

+0.155 (+3.00%)

, HSIC

Henry Schein

$75.25 /

+0.02 (+0.03%)

, NVST

Envista

$42.82 /

+0.14 (+0.33%)

, PDCO

Patterson Companies

$30.25 /

-0.03 (-0.10%)

, XRAY

Dentsply Sirona

$62.18 /

+0.08 (+0.13%)

, ALGN

Align Technology

$706.51 /

+4.81 (+0.69%)

Tens of millions of older…

Tens of millions of older Americans who cannot afford dental care - with severe consequences for their overall health, what they eat and even when they smile - may soon get help as Democrats maneuver to add dental benefits to Medicare for the first time in its history, The New York Times' Margot Sanger-Katz reports. The proposal, part of the large budget bill moving through Congress, would be among the largest changes to Medicare since its creation in 1965 but would require overcoming resistance from dentists themselves, who are worried that it would pay them too little, the author notes. Publicly traded companies in the space include Align (ALGN), SmileDirectClub (SDC), Henry Schein (HSIC), Envista (NVST), Patterson Companies (PDCO) and Dentsply Sirona (XRAY). Reference Link

ShowHide Related Items >><<
XRAY Dentsply Sirona
$62.18 /

+0.08 (+0.13%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

NVST Envista
$42.82 /

+0.14 (+0.33%)

HSIC Henry Schein
$75.25 /

+0.02 (+0.03%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Wolfe Research
SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 Loop Capital
SmileDirectClub price target lowered to $6 from $9 at Loop Capital
HSIC Henry Schein
$75.25 /

+0.02 (+0.03%)

08/05/21 Credit Suisse
Henry Schein assumed with a Neutral at Credit Suisse
08/04/21 Barrington
Henry Schein price target raised to $95 from $91 at Barrington
08/03/21 Piper Sandler
Henry Schein price target raised to $95 from $89 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
NVST Envista
$42.82 /

+0.14 (+0.33%)

08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

08/05/21
Fly Intel: Top five analyst initiations
08/05/21 Credit Suisse
Patterson Companies assumed with an Outperform at Credit Suisse
06/24/21 Baird
Patterson Companies price target lowered to $35 from $37 at Baird
XRAY Dentsply Sirona
$62.18 /

+0.08 (+0.13%)

08/09/21 H.C. Wainwright
Dentsply Sirona price target lowered to $66 from $72 at H.C. Wainwright
08/06/21 Barrington
Dentsply Sirona price target raised to $79 from $77 at Barrington
08/06/21 Piper Sandler
Dentsply Sirona weakness a buying opportunity, says Piper Sandler
ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

08/05/21 Credit Suisse
Align Technology assumed with an Outperform at Credit Suisse
07/29/21 Credit Suisse
Align Technology price target raised to $732 from $715 at Credit Suisse
07/29/21 Piper Sandler
Align Technology price target raised to $775 from $735 at Piper Sandler
XRAY Dentsply Sirona
$62.18 /

+0.08 (+0.13%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

NVST Envista
$42.82 /

+0.14 (+0.33%)

HSIC Henry Schein
$75.25 /

+0.02 (+0.03%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

NVST Envista
$42.82 /

+0.14 (+0.33%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

Recommendations
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs » 07:07
08/10/21
08/10
07:07
08/10/21
07:07
SDC

SmileDirectClub

$6.71 /

-0.12 (-1.76%)

, ALGN

Align Technology

$686.46 /

-6.84 (-0.99%)

, XRAY

Dentsply Sirona

$59.56 /

-0.73 (-1.21%)

, NVST

Envista

$40.33 /

-0.85 (-2.06%)

Goldman Sachs analyst…

Goldman Sachs analyst Nathan Rich lowered the firm's price target on SmileDirectClub (SDC) to $4 from $7 and keeps a Sell rating on the shares after the company reported Q2 revenue and adjusted EBITDA that fell short of the firm's view and consensus while also providing FY21 revenue guidance that was 7% below consensus at the midpoint of the range. The weakness - which "stands in contrast to peers" given that Align Technology (ALGN), Dentsply Sirona (XRAY) and Envista (NVST) all reported strong Q2 results for their clear aligner businesses - suggests "the competitive environment may be a factor," argues Rich.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$59.56 /

-0.73 (-1.21%)

SDC SmileDirectClub
$6.71 /

-0.12 (-1.76%)

NVST Envista
$40.33 /

-0.85 (-2.06%)

ALGN Align Technology
$686.46 /

-6.84 (-0.99%)

SDC SmileDirectClub
$6.71 /

-0.12 (-1.76%)

08/10/21 Stephens
SmileDirectClub downgraded to Equal Weight from Overweight at Stephens
08/10/21 Stephens
SmileDirectClub downgraded to Equal Weight from Overweight at Stephens
08/10/21 William Blair
SmileDirectClub downgraded to Market Perform from Outperform at William Blair
08/10/21 JPMorgan
SmileDirectClub downgraded to Underweight from Neutral at JPMorgan
ALGN Align Technology
$686.46 /

-6.84 (-0.99%)

08/05/21 Credit Suisse
Align Technology assumed with an Outperform at Credit Suisse
07/29/21 Credit Suisse
Align Technology price target raised to $732 from $715 at Credit Suisse
07/29/21 Piper Sandler
Align Technology price target raised to $775 from $735 at Piper Sandler
07/09/21
Fly Intel: Top five analyst upgrades
XRAY Dentsply Sirona
$59.56 /

-0.73 (-1.21%)

08/09/21 H.C. Wainwright
Dentsply Sirona price target lowered to $66 from $72 at H.C. Wainwright
08/06/21 Barrington
Dentsply Sirona price target raised to $79 from $77 at Barrington
08/06/21 Piper Sandler
Dentsply Sirona weakness a buying opportunity, says Piper Sandler
08/05/21 Credit Suisse
Dentsply Sirona assumed with an Outperform at Credit Suisse
NVST Envista
$40.33 /

-0.85 (-2.06%)

08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/06/21 Credit Suisse
Envista price target raised to $55 from $49 at Credit Suisse
XRAY Dentsply Sirona
$59.56 /

-0.73 (-1.21%)

SDC SmileDirectClub
$6.71 /

-0.12 (-1.76%)

NVST Envista
$40.33 /

-0.85 (-2.06%)

ALGN Align Technology
$686.46 /

-6.84 (-0.99%)

  • 24
    Nov
  • 19
    Nov
XRAY Dentsply Sirona
$59.56 /

-0.73 (-1.21%)

SDC SmileDirectClub
$6.71 /

-0.12 (-1.76%)

NVST Envista
$40.33 /

-0.85 (-2.06%)

ALGN Align Technology
$686.46 /

-6.84 (-0.99%)

XRAY Dentsply Sirona
$59.56 /

-0.73 (-1.21%)

SDC SmileDirectClub
$6.71 /

-0.12 (-1.76%)

ALGN Align Technology
$686.46 /

-6.84 (-0.99%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.